Neurodegenerative disorders associated with MAPT mutations are bvFTD, primary progressive aphasia, progressive supranuclear palsy, corticobasal degeneration, and the FTD-parkinsonism and FTD-ALS clinical complexes [1, 2]. This evidence concerns the gene MAPT and amyotrophic lateral sclerosis.